| 1 | 药品名称 | DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 017608 | 产品号 | 001 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | HOSPIRA INC | |
| 2 | 药品名称 | POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 001 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | 参比药物 | 否 | ||
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 3 | 药品名称 | POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 002 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;105MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | 参比药物 | 否 | ||
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 4 | 药品名称 | POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 003 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | 参比药物 | 否 | ||
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 5 | 药品名称 | POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 004 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 6 | 药品名称 | POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 005 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 7 | 药品名称 | POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 006 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 8 | 药品名称 | POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 007 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 9 | 药品名称 | POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019367 | 产品号 | 008 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 处方药 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | AP | 参比药物 | 否 | |
| 批准日期 | 1985/04/05 | 申请机构 | BAXTER HEALTHCARE CORP | |
| 10 | 药品名称 | POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER | ||
| 申请号 | 019685 | 产品号 | 001 | |
| 活性成分 | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 市场状态 | 停止上市 | |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/100ML;5GM/100ML;104MG/100ML;600MG/100ML;310MG/100ML | |
| 治疗等效代码 | 参比药物 | 否 | ||
| 批准日期 | 1988/10/17 | 申请机构 | HOSPIRA INC | |
©2006-2020 DrugFuture->U.S. FDA Drugs Database
|